Skip to main content
logo
Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.800
+0.130 (3.54%)
Jul 2, 2026, 4:00 PM EDT - Market closed

Recursion Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
--644.76-463.66-328.07-239.48-186.48
Depreciation & Amortization
-83.736.4924.411.768.41
Stock-Based Compensation
-111.2281.6953.527.9114.84
Other Adjustments
-4.664.3433.066.6411.374.92
Changes in Accounts Payable
--2.626.44-0.991.771.75
Changes in Accrued Expenses
--9.745.269.42-0.0513.33
Changes in Unearned Revenue
--36.77-28.04-41.08110.32-10
Changes in Other Operating Activities
10.1362.81-30.41-11.62-7.11-5.38
Operating Cash Flow
-320.95-371.81-359.17-287.78-83.52-158.61
Capital Expenditures
--6.47-13.7-11.96-37.06-39.8
Purchases of Intangible Assets
--2.16-3.35-0.6-0.3-
Purchases of Investments
--3.81----301.14
Proceeds from Sale of Investments
---0.48230.6169.19
Other Investing Activities
--4.44277.11.84--
Investing Cash Flow
-9.94-16.87260.06-10.23193.25-271.74
Long-Term Debt Repaid
--8.43-4.44-0.77-0.09-12.8
Net Long-Term Debt Issued (Repaid)
--8.43-4.44-0.77-0.09-12.8
Issuance of Common Stock
-532.96308.56140.9154.44471.34
Net Common Stock Issued (Repurchased)
-532.96308.56140.9154.44471.34
Other Financing Activities
--3----
Financing Cash Flow
477.54521.53304.12140.13154.35458.54
Effect of Exchange Rate Changes on Cash and Cash Equivalents
9.3818.04-3.410.19-0.31-
Net Cash Flow
156.02150.9201.6-157.69263.7628.18
Free Cash Flow
-320.95-378.28-372.87-299.74-120.58-198.41
FCF Margin
-483.30%-506.52%-633.71%-672.43%-302.64%-1949.42%
Free Cash Flow Per Share
-0.67-0.85-1.36-1.44-0.69-1.58
Levered Free Cash Flow
-549.65-562.26-492.06-360.64-159.95-230.98
Unlevered Free Cash Flow
-570.39-557.08-501.8-377.59-166.11-214.47
SEC Filings: 10-K · 10-Q